A review of the role of immune therapy in HPV-associated head and neck squamous cell carcinoma, along with the evidence and perspective behind differing therapeutic considerations.
Mridula Krishnan, MD
Advertisement
Articles by Mridula Krishnan, MD
Advertisement
Latest Updated Articles
HPV and the Immune System in Head and Neck Cancers: Therapeutic ConsiderationsPublished: April 10th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
2
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
5
